Abant Izzet Baysal University
ibu.edu.trTotal trials
228
Active
62
Phase 3
0
Total enrollment
19,001
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 6 of 6 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Ultrasound-guided Suprascapular Nerve Block | — | — | — | — | — | 1 | |
| Anatomical Landmark-guided Suprascapular Nerve Block | — | — | — | — | — | 1 | |
| Wrist local steroid | — | — | — | — | — | 1 | |
| Beta Blocker | — | — | — | — | — | 1 | |
| ACE inhibitor | — | — | — | — | — | 1 | |
| Calcium channel blocker | — | — | — | — | — | 1 |
Next readouts
- 2023-07-30
- 2025-03-30
- 2026-06-30
Top conditions
- Stroke13
- Anxiety10
- Periodontitis7
- Healthy7
- Cerebral Palsy7
- Nursing Caries6
- Hemiplegia5
- Diabetes Mellitus, Type 25
Frequently asked questions about Abant Izzet Baysal University
- How many clinical trials does Abant Izzet Baysal University have on ClinicalTrials.gov?
- Abant Izzet Baysal University is listed as the lead sponsor on 228 clinical trials in ClinicalTrials.gov, 62 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Abant Izzet Baysal University's trials are in Phase 3?
- 0 of Abant Izzet Baysal University's trials are in Phase 3, spread across 6 active drug programs.
- What therapeutic areas does Abant Izzet Baysal University focus on?
- Abant Izzet Baysal University's most-studied conditions on ClinicalTrials.gov are Stroke, Anxiety, Periodontitis, Healthy, Cerebral Palsy.
- When are Abant Izzet Baysal University's next clinical trial readouts?
- Abant Izzet Baysal University has 3 upcoming primary-completion readouts tracked here; the soonest is “Comparison of the Efficacy of Different Treatment Methods in Patients With Carpal Tunnel Syndrome”, expected around 2023-07-30.